APA (7th ed.) Citation

XC, C., CJ, Y., YT, P., YP, C., D, S., J, C., . . . LC, C. (2025). α6GABAA receptor positive allosteric modulators targeting trigeminal ganglia for preventing and aborting chronic periorbital allodynia and cephalic pain in both sexes: A mechanistic and comparative preclinical study. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 189, 118344. https://doi.org/10.1016/j.biopha.2025.118344

Chicago Style (17th ed.) Citation

XC, Chang, Yeh CJ, Pan YT, Chen YP, Sharmin D, Cook J, Pei YC, and Chiou LC. "α6GABAA Receptor Positive Allosteric Modulators Targeting Trigeminal Ganglia for Preventing and Aborting Chronic Periorbital Allodynia and Cephalic Pain in Both Sexes: A Mechanistic and Comparative Preclinical Study." Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 189 (2025): 118344. https://doi.org/10.1016/j.biopha.2025.118344.

MLA (9th ed.) Citation

XC, Chang, et al. "α6GABAA Receptor Positive Allosteric Modulators Targeting Trigeminal Ganglia for Preventing and Aborting Chronic Periorbital Allodynia and Cephalic Pain in Both Sexes: A Mechanistic and Comparative Preclinical Study." Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, vol. 189, 2025, p. 118344, https://doi.org/10.1016/j.biopha.2025.118344.